Pfizer

Pfizer reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 1,197 Kt (-72 /-5.7% y-o-y). Also positively, carbon intensity plunged to 29 t (-2.2 /-7.1% y-o-y).

Pfizer's Scope 3 emissions plunged to 3,818 Kt (-1,890 /-33.1% y-o-y). The parameter has been fairly volatile.

The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -51 Kt per annum over the period of FY2021 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Pfizer aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2030. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.